Clinical trial

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

NCT04941365

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2022-07-07

PhaseNA

Study timeline

Study start (actual)2022-07-07Date precision: day

Registry last updated2022-12-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Melanomaverified · MONDO: metastatic melanoma

Metastatic Breast Cancerunresolved

Advanced Renal Cell Carcinomaunresolved

Squamous Cell Carcinoma of Head and Neckverified · MONDO: head and neck squamous cell carcinoma

Non-small Cell Lung Cancer Stage IIIunresolved

Healthyunresolved

Interventions

single armDIAGNOSTIC_TEST

Sponsors & collaborators

Institut du Cancer de Montpellier - Val d'Aurellelead sponsor

Fondazione IRCCS ISTITUTO NAZIONALE TUMORIcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04941365 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.